As expected, expression of the fusion genes was restricted to tumours known to harbour the relevant translocation, with relative expression levels of PAX3-FKHR varying between 0.3- and 3.1-fold and those for PAX7-FKHR between 0.8- and 2.1-fold. The gene discussed is PAX3; the disease is neoplasm.